Tradestie Institutional Equity Comparison Engine
SGP vs NVS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NVS Overall Edge
NVS Captures Institutional Edge (3โ1 Pillars ยท 10โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Novartis AG (NVS) driven by superior Valuation, Growth & Margin, Options & Structure while SGP counters with relative strength in Momentum & Technical. Fundamentally, SGP trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus NVS at 16.1x Forward P/E and 34.0% operating margin (+4.7% YoY). In options structure, SGP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NVS sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
NVS
SGP N/M vs NVS 16.1x Fwd P/E
Growth & Margin Winner
NVS
Op Margin N/A vs 34.0% ยท YoY N/A vs +4.7%
Momentum & Technical Winner
SGP
1Y +22.1% vs +21.4% ยท 52W Pos 66% vs 78%
Options & Structure Winner
NVS
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (6th %ile IV)
SGP
US Equity
SGP
Institutional Equity
$32.24
-1.95% 1D
Market Cap
N/A
1M Return
+34.33%
1Y Return
+22.12%
Forward P/E
N/M
Unified AI Score
39.3 / 100
SELL
Tech 15.0
Fund 45.0
Flow 50.0
Mom 60.0
NVS
NYSE
Novartis AG
Pharmaceutical Preparations
$160.20
-0.19% 1D
Market Cap
$303.1B
1M Return
+6.36%
1Y Return
+21.45%
Forward P/E
16.1x
Unified AI Score
43.7 / 100
HOLD
Tech 37.0
Fund 37.0
Flow 50.0
Mom 21.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SGP +22.12%
NVS +21.45%
Spread: +19.7 pp (SGP Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
SGP TTM Op. Margin: N/A
NVS TTM Op. Margin: 34.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SGP vs NVS. Trailing 12-month operating profitability (SGP N/A vs NVS 34.0%) and valuation multiples (SGP N/M vs NVS 16.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SGP | NVS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $303.1B | Larger Scale | NVS |
| Trailing P/E Ratio Valuation | N/M | 30.6x | Lower Multiple | NVS |
| Forward P/E Ratio Valuation | N/M | 16.1x | Lower Multiple | NVS |
| Revenue Growth (YoY) Growth | N/A | +4.7% | Higher Growth | NVS |
| Operating Margin (TTM) Profitability | N/A | 34.0% | Higher Margin | NVS |
| Net Profit Margin Profitability | N/A | 17.5% | Higher Margin | NVS |
| Return on Equity (ROE) Capital Efficiency | N/A | 24.3% | Higher ROE | NVS |
| 52-Week Range Position Momentum | 66% ($17โ$40) | 78% ($123โ$170) | Stronger Trend | NVS |
| Beta / 30D Volatility Risk Regime | 1.38ฮฒ ยท 70% Vol | 0.31ฮฒ ยท 27% Vol | Lower Realized Risk | NVS |
| Unified Institutional Score Composite Signal | 39.3 / 100 (SELL) | 43.7 / 100 (HOLD) | Higher Composite | NVS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SGP vs NVS Buy Guide
SGP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
NVS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
6th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SGP nor NVS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.